Breast and Ovarian Cancer:
From Bench to Bedside
Saturday, October 23, 2010
8:00 am – 12:15 pm
Dana-Farber Cancer Institute
Jimmy Fund Auditorium
Boston, MA
Quicklinks
Course Objectives | Agenda | Faculty
Registration Information | Directions
Offered by Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School Department of Continuing Education
Course Objectives
This half-day course will provide medical oncologists; surgical oncologists; radiation oncologists; nurse practitioners; and other interested clinicians with the opportunity to advance their knowledge of breast and ovarian cancer and their commonalities. Through a series of lectures and interactive case discussions, attendees will gain a better understanding of BRCA1/2 syndromes, ovarian cancer advances, triple-negative breast cancer, and the current use and future potential of DNA targets as breast and ovarian cancer treatments. The session will review key scientific advances related to these cancers, and apply them to clinical practice.
Participants are invited to submit a challenging case from their own practices in advance of the course for consideration at two related case discussion sessions.
The Women's Cancers Program at Dana-Farber/Brigham and Women's Cancer Center
The Women's Cancers Program brings together a team of renowned experts in breast and gynecologic cancers to provide women with the most promising cancer treatments available. With an equal commitment to clinical research and care, the faculty is able to facilitate the rapid conversion of scientific discoveries into lifesaving treatments. In addition to offering the latest treatments, the Center also provides a wide range of specialized treatment programs and other services – from support groups to complementary therapies – to help meet the diverse needs of women facing cancer.
Agenda
8:00 am
Registration and Continental Breakfast
8:25 am
Welcome
Ursula A. Matulonis, MD
Session I
Moderator: Ursula A. Matulonis, MD
8:30 am
BRCA1/BRCA2 Syndromes:
Challenges and Opportunities
Beth Overmoyer, MD, FACP
8:50 am
Ovarian Cancer: What's in the Pipeline?
Ursula A. Matulonis, MD
9:10 am
Questions and Answers
9:25 am
Challenging Cases: Panel Discussion
Moderator: Neil S. Horowitz, MD
10:05 am
Break
Session II
Moderator: J. Dirk Iglehart, MD
10:20 am
Triple-Negative Breast Cancer:
Problems and Possibilities
Nancy U. Lin, MD
10: 40 am
Targeting DNA: Finding an Achilles Heel
• The View from the Lab – J. Dirk Iglehart, MD
• New Targets in Breast Cancer – Erica L. Mayer, MD, MPH
• New Strategies for Ovarian Cancer – Joyce F. Liu, MD, MPH
11:25 am
Questions and Answers
11:40 am
Challenging Cases: Panel Discussion
Moderator: Ian E. Krop, MD, PhD
12:15 pm
Closing Remarks
J. Dirk Iglehart, MD
Challenging Case Submissions
Interested attendees are invited to submit a one paragraph description of a challenging case, focusing on risk, surgical management, or systematic therapy issues, and clearly stating the clinical question(s) of interest. To be considered, cases must be emailed to candace_lowe@dfci.harvard.edu by Thursday, October 14th.
Faculty
J. Dirk Iglehart, MD, Course Co-Director
Director, Women's Cancers Program
Dana-Farber/Brigham and Women's Cancer Center;
Anne E. Dyson Professor of Women's Cancers and Surgery
Harvard Medical School
Ursula A. Matulonis, MD, Course Co-Director
Director, Medical Gynecologic Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School
Neil S. Horowitz, MD
Director, Clinical Research in Gynecologic Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Obstetrics, Gynecology and
Reproductive Biology, Harvard Medical School
Ian E. Krop, MD, PhD
Medical Oncologist, Women's Cancers Program
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
Nancy U. Lin, MD
Medical Oncologist, Women's Cancers Program
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
Joyce F. Liu, MD, MPH
Medical Oncologist, Women's Cancers Program
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine, Harvard Medical School
Erica L. Mayer, MD, MPH
Medical Oncologist, Women's Cancers Program
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine, Harvard Medical School
Beth Overmoyer, MD, FACP
Medical Oncologist, Women's Cancers Program
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.
Harvard Medical School designates this educational activity for a maximum of 3.5 AMA PRA Category 1 credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
Registration Information
Registration Fee: $35 and includes course materials and continental breakfast. The registration fee is non-refundable.
To register by mail
To register by mail, send completed form and check payable to DF/BWCC to:
Breast and Ovarian Cancer CME
Attn: Kamira Wooten
44 Binney Street, OS 381
Boston, MA 02115
Registration form must be postmarked no later than October 12, 2010.
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call (800) 553-3787.
Directions
The Jimmy Fund Auditorium at Dana-Farber Cancer Institute is located at 35 Binney Street in Boston. Complimentary parking is available at One Jimmy Fund Way.
